Interim Financial Report for Q3 2014 for the BioPorto Group

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Interim Financial Report for Q3 2014 for the BioPorto Group

Summary of Q3 2014

Strategic Development
 

  • In Q3 2014 BioPorto has maintained its focus on commercialization of The NGAL Test ™.  Since June 2014 four additional new routine users of The NGAL Test ™ were added in Europe, bringing the total up to 13. The development in licensing and OEM agreements confirms the interest from potential distribution partners, but this interest is not expected to lead to new agreements in 2014.
  • New products, both kits and antibodies, have been in-licensed to BioPorto’s product portfolio. The intention is to expand the product portfolio and generate additional sales on the strengths of the existing sales platform.
  • BioPorto has been awarded Frost & Sullivan’s 'Product Leadership Award'. Frost & Sullivan found that The NGAL Test ™ is the best-positioned NGAL product on the market with unique features for the diagnosis of acute kidney injury (AKI).
  • BioPortos sample collection for a clinical trial in the United States is progressing according to the plan. The management expects that the sample collection phase will be completed in the first quarter of 2015, so that the study phase can be completed and the FDA filing be submitted in the first half year of 2015.

Financial development
 

  • BioPortos revenue in the first nine months of 2014 was DKK 13.8 mio. (2013: DKK 12.2 mio.), representing a growth of 13%. Sales in the third quarter of 2014 amounted to DKK 4.6 mio. (2013: DKK 5.0 mio.).
  • Profit after tax for the first nine months of 2014 was improved by DKK 6.5 mio. to DKK -10.7 mio. (2013: DKK -17.2 mio.).
  • Sales of the group’s NGAL products for human diagnostics, including The NGAL Test ™, amounted to DKK 3.1 mio. in the first nine months of 2014 (2013: DKK 2.8 mio.). Of this, The NGAL Test ™ amounted to DKK 1.9 mio.

Expectations for 2014

  • Due to a delay in the execution of licensing and OEM agreements, the revenue expectations can be narrowed from DKK 19-23 mio. to around DKK 19 mio., representing a growth of 15%.
  • As a consequence of the above, expectations for net profit after taxes is narrowed from a loss of DKK 10-14 mio to a loss of around DKK 14 mio.

  
Peter Morch Eriksen, CEO, comments: "Although I expected to have signed additional license and OEM agreements in 2014, I am pleased that our focus on increasing the number of routine users in Europe of The NGAL Test ™ is now showing results. This is the first and important step towards ensuring broad commercialization of our marker - and thus an important milestone in the execution of our strategy to double sales and make BioPorto cash flow positive. "

Investor Meeting
 

In connection with the publication of the interim report for the first 9 months of 2014, BioPorto’s investor meeting will take place on November 7, 2014, at 15.00 p.m. at the company's address, Tuborg Havnevej 15 st., 2900 Hellerup.

Further details:

Peter Mørch Eriksen, CEO

Christina Thomsen, Investor Relations

Tel.: +45 4529 0000

E-mail: investor@bioporto.com

About BioPorto

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX Copenhagen stock exchange.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 92

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
Condo Downsizing Demands More Than a Price Check Today

Updated Category News Views 22

A smaller front door can hide a surprisingly large stack of obligations. That is the useful point in the HelloNation guidance featuring Chevy Chase real estate expert Lise Howe: downsizing into a condo is not merely a square-footage trade. It is a decision about recurring costs, building stewardship, daily friction, and whether the place still works when life gets less...

Continue Reading
Pressure Injury Care Needs More Than Awareness Alone

Updated Category News Views 14

Wet skin does not care how polished the awareness campaign looks. That is the uncomfortable truth sitting underneath Worldwide Pressure Injury Prevention Day, the annual observance held on the third Thursday of November. Pressure injuries remain a stubborn problem across healthcare facilities and home care settings because prevention is not one tidy action; it is a chain...

Continue Reading
CloudBackend's €6.6M Test: Can Vibe Code Become SaaS?

Updated Category News Views 21

A prototype is cheap theatre; keeping it alive after customers arrive is where the bill lands. CloudBackend has raised €6.6 million to attack that unglamorous, absolutely vital stretch between an AI-made app and an actual software business. The round is led by Carl-Henric Svanberg's family office, while existing backer M2 Asset Management increased its stake. That is a...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 286

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading
Canadian Solar's Storage Deal Has Real Staying Power

Updated Category News Views 18

Five battery projects and 22-year service contracts are the sort of details that make me stop squinting at renewable-energy headlines. Canadian Solar's e-STORAGE unit has signed agreements with X-ELIO to supply 590 MW and 1.43 GWh of battery energy storage across four Texas projects and one in New South Wales, Australia. That is not a vague memorandum, not a pilot, and...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 11

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 46

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 292

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

CareConnect Unveils Revolutionary Home Care Insights Platform

Updated Category News Views 233

CareConnect unveils Home Care Insights CareConnect, LLC—known for AI-driven home care software and services—has introduced Home Care Insights, a new way to see and manage the caregiver workforce. The goal is simple: give agencies timely, usable insight into recruitment, engagement, and retention so they can staff confidently and deliver dependable care. Home Care...

Continue Reading
Dragon Boats and Poetry: Yichang's Festival Unleashed

Updated Category News Views 58

Yichang's Grand Festival: A Cultural Tapestry Unfolds In a world that's constantly spinning with change, there's something comforting about tradition. On June 21, Yichang in central China's Hubei Province, lit up with a flurry of festivities as the Dragon Boat Festival kicked off. Now, this isn't just about boats skimming down a river. It's a celebration that knits...

Continue Reading
Corero Network Security Expands Growth with $6 Million Orders

Updated Category News Views 187

Corero Network Security Announces New Orders Corero Network Security, a renowned provider in the field of DDoS protection, recently marked a significant milestone by securing $6 million in new orders, demonstrating its ongoing growth and success. This achievement comes as the company wraps up the third quarter of 2024, bringing its total orders for the year to an...

Continue Reading
Iridex's Innovative Study on MicroPulse Treatment for DME

Updated Category News Views 181

Revolutionizing Diabetic Macular Edema Treatment MOUNTAIN VIEW, Calif. – Iridex Corporation (Nasdaq: IRIX), a leader in laser-based medical systems, has taken a remarkable step forward in the treatment of diabetic macular edema (DME). The company recently announced the successful enrollment of the first patient in the DAME Trial. This pivotal study aims to assess the...

Continue Reading
Envision Energy Partners with TÜV Nord to Enhance Wind Power Innovation

Updated Category News Views 120

Envision Energy Partners with TÜV Nord for Wind Power Innovation In a move sending ripples through the renewable energy sector, Envision Energy recently teamed up with TÜV Nord at the WindEnergy Hamburg event. Their signing of a cooperation memorandum marks not just paperwork, but a serious commitment to reshape the landscape of wind power technology. What's Fueling...

Continue Reading